FI5957U1 - Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella - Google Patents

Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella

Info

Publication number
FI5957U1
FI5957U1 FI20020420U FIU20020420U FI5957U1 FI 5957 U1 FI5957 U1 FI 5957U1 FI 20020420 U FI20020420 U FI 20020420U FI U20020420 U FIU20020420 U FI U20020420U FI 5957 U1 FI5957 U1 FI 5957U1
Authority
FI
Finland
Prior art keywords
tamsulosin
solution
related compounds
dissolving
sulfonate salt
Prior art date
Application number
FI20020420U
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Hans Jan Hoorn
Theodorud Hendricus Ant Peters
Jaroslav Pis
Radim Scigel
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of FIU20020420U0 publication Critical patent/FIU20020420U0/fi
Application granted granted Critical
Publication of FI5957U1 publication Critical patent/FI5957U1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • C07C303/44Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20020420U 2001-10-31 2002-10-23 Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella FI5957U1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33081701P 2001-10-31 2001-10-31
US10/208,009 US6835853B2 (en) 2001-10-31 2002-07-31 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith

Publications (2)

Publication Number Publication Date
FIU20020420U0 FIU20020420U0 (fi) 2002-10-23
FI5957U1 true FI5957U1 (fi) 2003-09-30

Family

ID=26902810

Family Applications (2)

Application Number Title Priority Date Filing Date
FI20020420U FI5957U1 (fi) 2001-10-31 2002-10-23 Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella
FI20020421U FI5816U1 (fi) 2001-10-31 2002-10-23 Raseeminen tamsulosiinivapaa emäs

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20020421U FI5816U1 (fi) 2001-10-31 2002-10-23 Raseeminen tamsulosiinivapaa emäs

Country Status (17)

Country Link
US (2) US6835853B2 (zh)
EP (2) EP1444198A1 (zh)
CN (2) CN100343227C (zh)
AT (2) ATE417822T1 (zh)
AU (2) AU2002330774B9 (zh)
CA (2) CA2464648C (zh)
CH (3) CH697164A5 (zh)
CZ (2) CZ13392U1 (zh)
DE (3) DE60230438D1 (zh)
DK (2) DK200200338U3 (zh)
FI (2) FI5957U1 (zh)
FR (2) FR2832147B1 (zh)
IL (2) IL161449A0 (zh)
IS (2) IS6602A (zh)
NL (2) NL1021671C2 (zh)
NO (1) NO20042256L (zh)
WO (2) WO2003037850A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
USH2154H1 (en) * 2003-10-08 2006-04-04 Farmak, A.S. Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
US8436029B2 (en) * 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
CN100545148C (zh) 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
WO2006117662A2 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Polymorphic forms of (r)-(-)-tamsulosin
US20090137844A1 (en) * 2005-06-15 2009-05-28 Fermion Oy Crystallization process
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
DE102008002409A1 (de) * 2008-06-13 2009-12-17 Evonik Goldschmidt Gmbh Enzymatische Synthese von Sphingolipiden
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2338876A1 (en) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Tamsulosin adipate for pharmaceutical use
KR101525493B1 (ko) * 2013-01-02 2015-06-03 보령제약 주식회사 고순도 탐술로신 또는 이의 염 제조방법
CN104926699B (zh) * 2015-07-02 2018-09-25 成都丽凯手性技术有限公司 一种高光学纯度盐酸坦索罗辛的制备方法
CN106631918B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 拆分坦索罗辛对映异构体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383998A (de) * 1959-08-05 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3261829A (en) * 1964-08-12 1966-07-19 Searle & Co Spiro(steroidal-6,3'-1-pyrazolines) and process
CA1147342A (en) 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
ES2098069T3 (es) * 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
AU2002330774B2 (en) 2009-06-04
FIU20020421U0 (fi) 2002-10-23
AT6687U1 (de) 2004-02-25
CA2464648C (en) 2009-07-14
CN1578761A (zh) 2005-02-09
CN1578762A (zh) 2005-02-09
US20030109752A1 (en) 2003-06-12
CN100579958C (zh) 2010-01-13
EP1444199B1 (en) 2008-12-17
DK200200338U3 (da) 2003-07-11
IL161449A0 (en) 2004-09-27
FR2832147A1 (fr) 2003-05-16
AU2002330776B2 (en) 2009-03-12
DE20216835U1 (de) 2003-09-25
AU2002330774B9 (en) 2010-01-07
DE60230438D1 (de) 2009-01-29
CZ13392U1 (cs) 2003-06-24
FIU20020420U0 (fi) 2002-10-23
NO20042256L (no) 2004-07-28
US6965051B2 (en) 2005-11-15
CZ13580U1 (cs) 2003-08-18
CH697034A5 (de) 2008-03-31
IS6602A (is) 2003-05-02
ATE417822T1 (de) 2009-01-15
WO2003037851A1 (en) 2003-05-08
DK200200338U1 (da) 2003-01-31
IL161490A0 (en) 2004-09-27
CA2464648A1 (en) 2003-05-08
FI5816U1 (fi) 2003-06-06
DE20216779U1 (de) 2003-09-04
US20050096394A1 (en) 2005-05-05
EP1444199A1 (en) 2004-08-11
CN100343227C (zh) 2007-10-17
US6835853B2 (en) 2004-12-28
CH697164A5 (de) 2008-05-30
DK200200339U1 (da) 2003-01-31
WO2003037850A1 (en) 2003-05-08
IS6603A (is) 2003-05-02
FR2832147B1 (fr) 2006-06-02
NL1021671C2 (nl) 2003-05-15
EP1444198A1 (en) 2004-08-11
DK200200339U3 (da) 2003-06-13
CA2464917A1 (en) 2003-05-08
FR2832146B1 (fr) 2006-05-26
CH696665A5 (de) 2007-09-14
CA2464917C (en) 2009-06-02
FR2832146A1 (fr) 2003-05-16
NL1021678C2 (nl) 2003-05-15

Similar Documents

Publication Publication Date Title
FI5957U1 (fi) Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
NO2014011I1 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
DK1307576T3 (da) Fortyndet syre/metalsalt-hydrolyse af lignocelluloser
EP2213674A4 (en) CLEANING PROCEDURE FOR PEMETREXED SALTS, SODIUM SALT AND SODIUM SALT
IS7148A (is) Aðferðir til að framleiða kalsíumsaltform statína
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
IS8217A (is) Bætt framleiðsla rósúvastatínkalsíumsalts
DK1539711T3 (da) Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
AU7253801A (en) Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof
DE50106029D1 (de) Verfahren zur Herstellung von Polycarbonat
IS6987A (is) Nýjar súlfónsýru afleiður
BRPI0410553B1 (pt) processo para a produÇço contÍnua de alquilamino(met)acrilamida
DOP2002000390A (es) Sal citrato de 5,8 14-hiezatetraciclo [10.3.1.0 2,11. 0.4.9] hexadeca-2(11),3,5,8,9, pentaeno y composiciones farmaceuticas de las mismas
BR0213561B1 (pt) processo para a preparaÇço de amidas de Ácido 2-halopiridincarboxÍlico.
MXPA05013607A (es) Candidatos de farmaco farmaceuticos mejorados y metodos para preparar los mismos.
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
DE602004021052D1 (de) Herstellungsverfahren von Xylylendiamin
DE60214629D1 (de) Verfahren zur Zersetzung von Michael-Addukten
PT1513806E (pt) Sais de ácido sulfónico de derivados do ácido mandélico
FR2837502B1 (fr) PROCEDE D'ELECTRODEPOSITION D'ALLIAGES Ni-Fe-P UTILISANT UNE SOLUTION DE SULFAMATE
ITMI20002187A0 (it) Processo per la produzione dell'acido r(+) -lipico
IS7477A (is) Aðferð við framleiðslu sýrusalts af gemifloxasíni
FI20000867A (fi) Menetelmä klooridioksidin valmistamiseksi eri pelkistimien yhteiskäytöllä
BR0214971A (pt) Processo para a produção de um imunossupressor